Thank you for visiting our virtual exhibit space.
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 43 000 employees in 80 countries and marketed products in more than 170 countries.
With a history of 95 years of innovation and leadership in diabetes care, today our company is committed to the discovery and development of innovative treatments for diabetes, obesity, haemophilia and other rare non-malignant blood disease, NASH, atherosclerosis, heart failure, chronic kidney disease and growth disorders.
In partnership with everyday experts
Our Disease Experience Expert Panels (DEEPs) are made up of people living with serious chronic diseases – including patients and family members. These experts by experience provide us with disease-specific insights into their daily and long-term challenges.
Such insights guide every aspect of the way we work: from our research and development of innovative treatments, to supporting people with serious chronic diseases to achieve better health and a better quality of life.